ABVC BioPharma Inc. (NASDAQ: ABVC) Stock Information | RedChip

ABVC BioPharma Inc. (NASDAQ: ABVC) Listen to this Section


$0.78
+0.0299 ( +3.99% ) 142.8K

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Market Data


Open


$0.78

Previous close


$0.75

Volume


142.8K

Market cap


$8.57M

Day range


$0.71 - $0.79

52 week range


$0.60 - $3.35

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 15, 2024
10-q Quarterly Reports 91 Aug 14, 2024
8-k 8K-related 13 Jul 23, 2024
8-k 8K-related 13 Jul 12, 2024
8-k/a 8K-related 15 Jun 25, 2024
8-k/a 8K-related 15 Jun 24, 2024
8-k 8K-related 17 May 24, 2024
8-k 8K-related 17 May 24, 2024
8-k 8K-related 15 May 23, 2024
8-k 8K-related 15 May 23, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.